Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Accrued Liabilities

9 Months Ended

Sep. 30, 2012

5. Accrued Liabilities

Accrued expenses consisted of the following:


($ in thousands)	As of September 30, 2012		As of December 31, 2011
Salaries, bonuses and related benefits	$	756	$	493
Professional fees		261		215
Research and development expenses		936		653
Accrued milestones		1,500		1,500
Other		56		38

Total accrued expenses	$	3,509	$	2,899

Accrued milestones at September 30, 2012 and December 31, 2011 include $1.5 million due to OvaMed which is required to be paid in November 2012.